These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15211251)

  • 61. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Common lung conditions: acute dyspnea.
    Delzell JE
    FP Essent; 2013 Jun; 409():17-22. PubMed ID: 23767418
    [TBL] [Abstract][Full Text] [Related]  

  • 63. B-type natriuretic peptide measurement in heart failure.
    Spevack DM; Schwartzbard A
    Clin Cardiol; 2004 Sep; 27(9):489-94. PubMed ID: 15471158
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A national campaign for the promotion of the appropriate use of natriuretic peptide assays in heart failure patients].
    Di Lenarda A
    G Ital Cardiol (Rome); 2016 Jan; 17(1):48-50. PubMed ID: 26901258
    [No Abstract]   [Full Text] [Related]  

  • 65. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?
    Rodeheffer RJ
    J Am Coll Cardiol; 2004 Aug; 44(4):740-9. PubMed ID: 15312852
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea.
    Mueller C
    ACP J Club; 2005; 142(1):A14-5; author reply A15. PubMed ID: 15690582
    [No Abstract]   [Full Text] [Related]  

  • 67. Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea.
    Schwam E
    ACP J Club; 2005; 142(1):A14; author reply A15. PubMed ID: 15656541
    [No Abstract]   [Full Text] [Related]  

  • 68. Potential costs of B-type natriuretic peptide for the identification of people with heart failure in primary care in Scotland - a pilot study.
    Chapman AR; Leslie SJ; Walker SW; Bickler C; Denvir MA
    J R Coll Physicians Edinb; 2015 Mar; 45(1):27-32. PubMed ID: 25874827
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The value of BNP determination in general practice].
    Finsterer S; Nentwich Ch; Silber S
    MMW Fortschr Med; 2004 Sep; 146(37):36, 38-40. PubMed ID: 15887700
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea.
    Murray H; Cload B; Collier CP; Sivilotti ML
    CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Diagnostic tests and ROC curves analysis].
    D'Arrigo G; Provenzano F; Torino C; Zoccali C; Tripepi G
    G Ital Nefrol; 2011; 28(6):642-7. PubMed ID: 22167615
    [No Abstract]   [Full Text] [Related]  

  • 74. Diagnostic utility of B-type natriuretic peptide in patients with acute dyspnea or pleural effusions.
    Zemans RL; Chatterjee K; Matthay MA
    Am J Med; 2004 Mar; 116(6):424-6. PubMed ID: 15006593
    [No Abstract]   [Full Text] [Related]  

  • 75. Should natriuretic peptide testing be incorporated into emergency medicine practice?
    Hohl CM
    CJEM; 2006 Jul; 8(4):259-61. PubMed ID: 17324305
    [No Abstract]   [Full Text] [Related]  

  • 76. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Brain natriuretic peptide and breathing not properly: the merger of 2 BNPs.
    Maisel A
    Clin Chem; 2012 Feb; 58(2):469-70. PubMed ID: 21965554
    [No Abstract]   [Full Text] [Related]  

  • 78. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal.
    Schwam E
    Acad Emerg Med; 2004 Jun; 11(6):686-91. PubMed ID: 15175210
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Experiences with serum BNP (B type natriuretic peptide) in patients with systolic and diastolic heart failure].
    Lukács I; Fey E; Kárpáti P
    Orv Hetil; 2005 Sep; 146(37):1919-23. PubMed ID: 16255376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Randomized Control Trial Using a Validated Prediction Model for Diagnosing Acute Heart Failure in Undifferentiated Dyspneic Emergency Department Patients-Results of the GASP4Ar Study.
    Steinhart BD; Levy P; Vandenberghe H; Moe G; Yan AT; Cohen A; Thorpe KE; McGowan M; Mazer CD
    J Card Fail; 2017 Feb; 23(2):145-152. PubMed ID: 27565045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.